NBI-98854

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for NBI-98854, covering 2011-04-20 to 2022-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome [Phase 2]